Aller au contenu principal
2026 article

1550-P: Domain-Specific and Dose-Response Effects of a New Digital Intervention for Diabetes Distress in Families of School-Aged Children Living with Type 1 Diabetes (T1D)

0Citations signalées — pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Introduction and Objective: We examined whether a new digital intervention targeting diabetes distress in families of school-aged children living with T1D produced domain-specific effects, offering insight into mechanisms of change. Methods: We randomized families (N=34; [mean±SD] child age=10±1.4 yr; 53% male; HbA1c=7.24±0.7%) to self-guided (app only [SG], n=13), enhanced self-guided (app+ 3 video visits [ESG], n=11), or app+ 8 video visits (VV, n=10). We compared parent and child Problem Areas in Diabetes-Child (PAID-C) domain scores pre-post treatment and by delivery arm. Results: Overall, parent and child PAID-C scores decreased (p=0.03), with no group differences. Parent reductions concentrated in domains: Keeping up with Demand, Personal Regimen Distress, and Child Regimen Distress (Cohen’s d=047-0.50); child reductions reflected changes in Emotional Burden (d=0.55). Exploratory analyses suggested greater app use predicted larger reductions in child Emotional Burden (=−1.4 points/hour, p=0.09). Conclusion: These findings extend beyond total scores by identifying which types of distress improved and suggest that app engagement could enhance child outcomes, pointing to practical ways to strengthen and expand the intervention. Disclosure S.R. Patton: Advisory Panel; Current; Glooko, Inc. A. Monzon: None. N. Kahhan: None. J.M. Redel: None. M. Benson: Advisory Panel; Ended; Sanofi. Speaker's Bureau; Ended; Beta Bionics, Inc. Advisory Panel; Ended; Alexion Pharmaceuticals, Inc. Research Support; Current; Novo Nordisk. Employee; Current; KiHealth. Stock/Shareholder; Current; KiHealth. Research Support; Current; Sanofi. Research Support; Ended; Chronocort Diurnal. L.A. Fox: None. Funding National Institutes of Health (DK127493)

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
1550-P: Domain-Specific and Dose-Response Effects of a New Digital Intervention for Diabetes Distress in Families of School-Aged Children Living with Type 1 Diabetes (T1D)
Date Crossref
05/06/2026
Éditeur
American Diabetes Association
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Diabetes Management and ResearchDiabetes Management and EducationMobile Health and mHealth Applications

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.